PG

Prenetics Global Limited

IPO

Public · Hong Kong, Hong Kong · Founded 2014

Headquarters
Hong Kong
Employees
501–1000
Founded
2014
Business Model
B2C
Type
Public

About

Founded in 2014, Prenetics is a global leader in genomic and diagnostic testing disrupting and decentralizing healthcare with a focus on prevention, diagnostics and personalized care. Led by serial entrepreneur Danny Yeung, the company is operational across 10 countries. Prenetics develops consumer genetic testing (CircleDNA) and early colorectal cancer screening, and provides COVID-19 rapid point-of-care and at-home diagnostic testing plus medical genetic testing. The company has received strategic funding from Prudential, Alibaba Group, Apis Partners, Beyond Ventures, Gobi Partners and others.

Summary

Prenetics Global Limited is a Fintech company based in Hong Kong, Hong Kong, founded in 2014. Investors include Kraken Ventures, Artisan Acquisition Corp and American Ventures.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Secondary MarketSecondary MarketJan 2026
$48.0M

Sign up to see all 2 rounds

SPAC Merger through Secondary Market — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Prenetics Global Limited on Indexed.vc
<a href="https://indexed.vc/companies/prenetics-global-limited"><img src="https://indexed.vc/api/badge/company/prenetics-global-limited" alt="Prenetics Global Limited on Indexed.vc" width="260" height="76" /></a>